Skip to content
Contact Us
0

News

The Latest from BIOHIT Healthcare

Find company news, product updates, and insights into how we’re supporting clinicians and partners.

Angela Gore

BIOHIT Appoints Market Access & Development Manager

BIOHIT HealthCare Ltd are pleased to announce the appointment of Angela Gore as Market Access & Development Manager. Following a successful few years of growth at BIOHIT, this announcement sees the expansion of the BIOHIT team. This new role will focus on developing networks within the NHS, improving the exposure of BIOHIT’s key products, and broadening the company’s market reach into new areas.

Read More
Dr Cinzia Papadia, GastroPanel Presentation BSGLive'24

BIOHIT HealthCare to host symposium on gastric cancer at BSG LIVE’24

BIOHIT HealthCare is attending BSG LIVE’24 at ICC Birmingham from the 17th to the 20th of June, where it will be showcasing its broad range of gastrointestinal diagnostic solutions. It will also be hosting a fascinating symposium discussing the use of GastroPanel® for gastric cancer risk assessment, presented by expert guest speaker, Dr Cinzia Papadia.

Read More
Current and future trends in IBD TDM Webinar

BIOHIT HealthCare to host webinar exploring current and future trends in TDM for IBD management

BIOHIT HealthCare is excited to announce an upcoming webinar on the Current and future trends in inflammatory bowel disease (IBD) therapeutic drug monitoring (TDM), which will take place on the 3rd of July at 12:30-1:30pm BST. The BIOHIT team will be joined by Rachel Nice, Section Lead for R&D and Specialist Services at Exeter Clinical Laboratory, and Rebecca Smith, Gastroenterology Specialist Registrar, both from the Royal Devon University Healthcare NHS Foundation Trust, to tackle the burning questions around this topical subject.

Read More
Dr. Christian Selinger & Prof. Jimmy Limdi

BIOHIT HealthCare to host webinar exploring TDM in gastrointestinal medicine

BIOHIT HealthCare is excited to announce its upcoming webinar entitled Proactive vs reactive therapeutic drug monitoring in inflammatory bowel disease (IBD). The event will take place on the 26th of October at 11 am, and will include a live Q&A with the expert speakers, Professor Jimmy Limdi and Dr Christian Selinger and moderated by The Clinical Services Journal.

Read More

BIOHIT HealthCare welcomes new regional sales manager to drive growth

BIOHIT is delighted to announce the appointment of Manraj Singh Ubhi as Regional Sales Manager, supporting the company’s ongoing growth across the West Midlands, Staffordshire, Wales and Merseyside. Manraj will play a key role in promoting BIOHIT’s unique gastroenterological diagnostic solutions and training clinicians on product use to improve patient care.

Read More
GastroPanel diagnostics tests

BIOHIT is exhibiting at the BSI congress 2022

BIOHIT is excited to be exhibiting at this year’s British Society for Immunology (BSI) Congress in Liverpool. The UK’s premier immunology event, taking place from the 5th to 8th of December, welcomes over 1,500 attendees – including scientists, researchers and clinical specialists – to witness a fascinating fusion of innovative research from around the world.

Read More

BIOHIT launches new quick test to help streamline gastroscopy referrals

BIOHIT Ltd will be attending the upcoming BSG Live 2023 conference in Liverpool, where it will unveil a revolutionary new test to support decision making for gastroscopy referrals and improve the early detection of gastric cancer. The GastroPanel® Quick Test diagnoses Helicobacter pylori infection, atrophic gastritis (AG) – a precancerous condition – and high gastric acid output in just 15 minutes, helping to triage patients in primary care and promote early discovery and treatment of gastrointestinal disorders.

Read More
GlutenDetect tests from BIOHIT determine gluten exposure

BIOHIT secures European distribution rights for Biomedal’s gluten immunogenic peptide tests

BIOHIT is excited to announce an agreement with Biomedal to supply its iVYLISA, iVYCHECK and GlutenDetect gluten immunogenic peptide (GIP) tests. Under this agreement, BIOHIT will have exclusive distribution rights over Biomedal’s range of rapid tests and immunoassays for gluten detection in the Czech Republic, Denmark, Finland, France, Hungary, Ireland, the Netherlands, Norway, Portugal, Sweden, Switzerland and the UK. BIOHIT will also have non-exclusive rights in all other European countries, excluding Italy and Spain.

Read More